FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Pacira Paying $3.5 Million for FCA Kickback Charges

The Justice Department says Pacira Pharmaceuticals is paying $3.5 million to resolve a whistleblower charge that it provided kickbacks to doctors to i...

Medical Devices

Neocis Yomi Edentulous Indication Cleared

FDA clears a Neocis 510(k) for a new Yomi edentulous indication for its robot-assisted dental surgery system.

Human Drugs

CDER Updates Inactive Ingredient Database

FDA updates its inactive ingredient database to allow users to perform electronic queries to obtain accurate maximum daily exposure information for ex...

Human Drugs

CARES Provision Should Speed OTC Changes: FDA

FDA tells the GAO that a provision in the CARES Act should help it address more quickly safety issues in OTC drugs.

Federal Register

Hikma Phenylbutazone ANADA Withdrawn

Federal Register notice: FDA withdraws approval of Hikma International Pharmaceuticals no-longer-marketed abbreviated new animal drug application for ...

Human Drugs

Draft Guide on Setting Endotoxin Limits for Cancer Therapies

FDA posts a draft guidance entitled Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products.

Medical Devices

Multiple Function Device Guidance

FDA issues a guidance on its regulatory approach and policy for multiple function device products.

Human Drugs

CGMP, Other Violations Seen in Eosera Inspection

FDA warns Eosera about CGMP and unapproved new drug violations in its production of OTC otic medications.

Human Drugs

CGMP, Unapproved New Drug Violations at Tender

FDA warns Tender about CGMP and unapproved and misbranded new drug violations in its production of several over-the-counter drug products.

Biologics

American Medical Aesthetics Stem Cell Products

CBER says American Medical Aesthetics and Regenerative Medicine is marketing stem cell products without a valid BLA in place.